Neuroscience Market Size, Share, and COVID-19 Impact Analysis, By Technology (Neuro-imaging, Neuro-microscopy, Electrophysiology, and Others), By Component (Instruments and Consumables), By End-User (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast 2026-2034

The global neuroscience market size was valued at USD 50.16 billion in 2025. The market is projected to grow from USD 53.01 billion in 2026 to USD 82.58 billion by 2034, exhibiting a CAGR of 5.7% during the forecast period.

Neuroscience refers to the scientific study of the nervous system, including the brain, peripheral nerves, and spinal cord. It covers various techniques such as neuro-imaging, neuro-microscopy, electrophysiology, and others, along with several instruments and consumables, to explore nervous system and its role in behavior, disease, and cognition.

Some of the key areas of neuroscience research include genes, brain cells, brain circuits, computational neuroscience (use of mathematical models for understanding the behavior of individual neurons and whole networks in the brain), and clinical research. Scientists are involved in developing advanced technologies to contribute to neuroscience research and market growth.

• According to the European Patent Office, in 2023, scientists invented an implantable brain-computer interface (BCI), Stentrode, which enabled paralyzed patients to communicate through their thoughts.

Neuroscience has extensive applications in drug development, understanding of brain function, diagnosis of neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease, and providing insights into the biological basis of mental illness, which aids in developing the treatment for psychiatry. The increase in the global prevalence of such neurodegenerative disorders and mental health conditions has increased the demand for the advancement of neuroscience technologies and the adoption of instruments and consumables, which propelled the growth of the global market.

• According to data published by the Parkinson’s Foundation, more than 10 million people are living with Parkinson’s disease across the globe and around 1 million in the U.S. The number is projected to rise to 1.2 million people by 2030 in the U.S.

Moreover, key companies in the market are focused on increasing their R&D investments, receiving product approvals, developing new products and technologies, partnerships, and collaborations to expand their market presence, thereby supporting the growth of the global market.

• For instance, in May 2023, the U.S. FDA approved Neurophet AQUA, an AI software, to enhance the assessment of brain atrophy through Magnetic Resonance Imaging (MRI).

Impact of COVID-19 on the Neuroscience Market

The COVID-19 pandemic had a negative impact on the neuroscience market in 2020. During the pandemic, several neurological device manufacturing companies experienced a decline in their sales, which affected their revenue. This decline was mainly due to the nationwide lockdown and strict regulations imposed by the governments of various countries. This led to a decline in neurosurgery, a shortage of consumables and neurological devices, and a disruption of the global supply chain. Furthermore, a workflow of clinical trials and R&D was also affected during the pandemic.

• For instance, in May 2020, as per the Alzheimer Research Forum, clinical research for Alzheimer’s in the U.S., Europe, and Australia postponed the observational cohort studies.

However, the pandemic accelerated the adoption of telemedicine and digital health solutions, which include remote patient monitoring and treatment options for neurological conditions. This potentially created new opportunities for the neuroscience market.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Neurodegenerative Diseases by Key Countries/Sub-regions
• Technological Advancements in Devices  
• Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
• Impact of COVID-19 on the Market

Analysis by Technology

Based on technology, the neuro-imaging segment held the largest revenue share of the global neuroscience market. The growth can be attributed to the increasing use of brain imaging devices, including MRI, CT Scans, and EEG (Electroencephalogram) in diagnostic centers, hospitals, and ambulatory surgical centers for the diagnosis of neurological conditions. Thus, an increase in the adoption of brain imaging is expected to surge the demand for brain imaging devices in the upcoming years. Moreover, the use of the latest technologies to enhance brain imaging for neuroscientific purposes fuels the segment growth.

• In November 2023, researchers at Weill Cornell Medicine, Cornell Tech and Cornell’s Ithaca campus used AI-selected natural images and AI-generated synthetic images as neuroscientific tools for studying the brain’s visual processing.

The neuro-microscopy segment is projected to grow at a significant CAGR over the forecast period owing to the advancements in neuro-microscopy. High-resolution imaging methods such as two-photon microscopy, super-resolution microscopy, and confocal microscopy have allowed researchers to visualize neural structures and activities with unprecedented detail, expanding their applications in neuroscience.

• In May 2023, according to the Society for Science & the Public, a nanotechnologist from the Massachusetts Institute of Technology announced the development of ultra-tiny electronic microscopic miniature machines that, upon entering the brain, can detect and reverse neurological disorders.

Regional Analysis

To gain extensive insights into the market, Download for Customization

North America is expected to hold the highest revenue share in the neuroscience market and maintain its dominant position during the forecast period. The growth is mainly attributed to the presence of established players involved in manufacturing, developing, and commercializing the products used for the diagnosis and treatment of neurological patients in this region.

The Asia Pacific market is projected to grow at a rapid pace over the forecast period. The growth can be credited to the impact of increasing healthcare spending in countries such as India and China. Moreover, initiatives from public bodies to provide innovative diagnostic and treatment options are projected to boost regional market growth.

Key Players Covered

The report includes the profiles of key players such as     , GE Healthcare, Leica Microsystems (DH Life Sciences, LLC.), Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Medtronic, Noldus Information Technology, Koninklijke Philips N.V., B. Braun SE, and others.

Key Industry Developments

• In December 2023, Bristol Myers Squibb acquired Karuna Therapeutics with the aim of accelerating the expansion and diversification of its neuroscience portfolio.
• In June 2023, ACROBiosystems, under its Aneuro brand in partnership with Diagnostic Biochips, launched in vivo electrophysiology solutions to advance neuroscience research. This collaborative effort by both companies accelerated the neurological drug discovery and commercialization.
• In February 2022, NeuroNexus Technologies announced the launch of the NeuroNexus Summa Framework. This solution was designed for experienced electrophysiologists and life science researchers looking to easily incorporate the electrical signal read-outs from biological cells and tissues into the research workflow.